|
|
|
PediaFlow(TM) VAD Consortium Receives $5.6 Million NIH Contract to Ready Device for Clinical Trials
Posted By: Anonymous | Posted On: Feb 13,2010 18:30 pm | View: 46
LaunchPoint Technologies, Inc. and its fellow Consortium members have been awarded a $5.6 million contract from the National Institutes of Health (NIH) to pursue the continued development of the PediaFlow(TM) VAD, a fully magnetically-levitated (maglev), implantable heart-assist device for infants and small children with congenital or acquired heart disease. The four-year program, known as 'Pumps for Kids, Infants, and Neonates (PumpKIN) Preclinical Program,' will enable the PediaFlow Consortium to complete preclinical testing and obtain FDA approval to begin clinical trials. The bearing-less blood pump is designed to offer excellent blood-compatibility with acceptably low energy consumption, and to ultimately provide up to six months of extended circulatory support for infants and children recovering from heart surgery or awaiting a heart transplant.
Read More: http://www.prweb.com/releases/PediaFlow-VAD/NIH-Funding/prweb3601194.htm
|
|
|
|